Mendel Biotechnology
Mendel Biotechnology, Inc. says it aims "to produce plants enhanced for food, feed, fiber, energy and aesthetic benefit without large increases in production acreage" and says it is
- dedicated to being a premier biotechnology company serving large agricultural companies with new genetic and chemical solutions and to becoming the leading seed company serving the bioenergy industry.[1]
As at July 2010, Mendel had been granted over 20 biotechnology and GM patents, as listed on its website.[2] Its interests include developing "energy grasses" for biomass and biofuels.[3]
In its 2008 Annual Report it lists two lines of business that were central to its growth in that year:
- a collaborative project with Monsanto on soybean yield, "the basis of which is a Mendel technology"[4]
- the establishment of "the first-ever field trials of genetically diverse Miscanthus varieties for biomass production in the United States"[5]
Mendel's 2009 Annual Report names 2009 as a "watershed year", demonstrated by two collaborative partnerships: one with Monsanto and the other with Bayer CropScience.[6]
Mendel's deal with Monsanto involved Monsanto's "initial deployment of our [Mendel's] platforms" for its "improved yield soybean".[7]
Mendel's deal with Bayer involved "developing chemical products which make crops more resistant to biotic and abiotic stress factors, which in turn will stabilize yields and improve crop productivity".[8]
Contents
Affiliations
As at June 2010, Mendel's "strategic partners" are:[9]
- Monsanto. Mendel calls Monsanto its "most important customer and collaborator for our technology business".[10]
- BP
- Bayer CropScience
- Selecta Klemm: a joint venture formed in 2006 — Ornamental Biosciences, Inc. — for the commercialization of ornamental crop varieties differentiated in the marketplace for improved growth and survival under a range of stresses.
- SweTree Technologies: a collaboration for the development of improved varieties of plantation forest tree species.
- ArborGen: a collaboration to improve stress tolerance in selected tree species.
People
Scientific advisory board
As of June 2010:[11]
- Dr. Elliot Meyerowitz
- Dr. Jonathan Jones
- Dr. Brian Staskawicz
- Dr. Fred Ausubel
- Dr. Ulrich Schirmer
- Dr. Andrew Millar
- Dr. Joseph R. Ecker
- Dr. Andrew H. Paterson
- Dr. Charles Wyman
Funding
Contact
As at July 2010:[12]
- Address: Mendel Biotechnology, 3935 Point Eden Way, Hayward, CA 94545
- Phone 510-264-0280
- Fax 510-264-0254
- http://www.Mendelbio.com
Resources
Notes
- ↑ Our mission, Mendel Biotechnology website, acc 9 Jun 2010
- ↑ Issued patents, Mendel Biotechnology website, acc 8 July 2010
- ↑ Mendel Biotechnology Annual Report 2008, p 4, acc 8 Jul 2010
- ↑ Mendel Biotechnology Annual Report 2008, p 4, acc 8 Jul 2010
- ↑ Mendel Biotechnology Annual Report 2008, p 4, acc 8 Jul 2010
- ↑ Dear Shareholder, Mendel Biotechnology Annual Report 2009, p. 4, acc 8 Jul 2010
- ↑ Dear Shareholder, Mendel Biotechnology Annual Report 2009, p. 4, acc 8 Jul 2010
- ↑ Dear Shareholder, Mendel Biotechnology Annual Report 2009, p. 4, acc 8 Jul 2010
- ↑ Strategic Partners, Mendel Biotechnology website, acc 9 Jun 2010
- ↑ Strategic Partners, Mendel Biotechnology website, acc 9 Jun 2010
- ↑ Scientific Advisory Board, Mendel Biotechnology website, acc 9 Jun 2010
- ↑ Mendel Biotechnology Annual Report 2009, acc 8 Jul 2010
